Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 87

    1.

    Sexual activity and Kaposi's sarcoma among human immunodeficiency virus type 1 and human herpesvirus type 8-coinfected men.

    Nawar EW, Cole SR, Farzadegan H, Witt MD, Jenkins FJ, Margolick JB, Phair JP, Jacobson LP.

    Ann Epidemiol. 2008 Jul;18(7):517-21. Epub 2008 May 27.PMID: 18504143 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Multiperson use of syringes among injection drug users in a needle exchange program: a gene-based molecular epidemiologic analysis.

    Shrestha S, Smith MW, Broman KW, Farzadegan H, Vlahov D, Strathdee SA.

    J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):335-43.PMID: 16980914 [PubMed - indexed for MEDLINE]Related articles

    3.

    Localization of human herpesvirus type 8 in human sperms by in situ PCR.

    Bagasra O, Patel D, Bobroski L, Abbasi JA, Bagasra AU, Baidouri H, Harris T, El-Roeiy A, Lengvarszky Z, Farzadegan H, Wood C.

    J Mol Histol. 2005 Sep;36(6-7):401-12. Epub 2006 Jan 10.PMID: 16402152 [PubMed - indexed for MEDLINE]Related articles

    4.

    Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy.

    Rusch ML, Farzadegan H, Tarwater PM, Safaeian M, Vlahov D, Strathdee SA.

    AIDS Behav. 2005 Sep;9(3):289-99.PMID: 16133905 [PubMed - indexed for MEDLINE]Related articles

    5.

    The effect of RANTES chemokine genetic variants on early HIV-1 plasma RNA among African American injection drug users.

    Duggal P, Winkler CA, An P, Yu XF, Farzadegan H, O'Brien SJ, Beaty TH, Vlahov D.

    J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):584-9.PMID: 15793370 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evaluation of possible effects of continued drug use on HIV progression among women.

    Rompalo AM, Shah N, Margolick JB, Farzadegan H, Arnsten J, Schuman P, Rich JD, Gardner LI, Smith DK, Vlahov D; HIV Epidemiology Research Study Group.

    Int J STD AIDS. 2004 May;15(5):322-7.PMID: 15117502 [PubMed - indexed for MEDLINE]Related articles

    7.

    High-risk behavior and potential transmission of drug-resistant HIV among injection drug users.

    Sethi AK, Celentano DD, Gange SJ, Gallant JE, Vlahov D, Farzadegan H.

    J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):503-10.PMID: 15021315 [PubMed - indexed for MEDLINE]Related articles

    8.

    Genetic influence of CXCR6 chemokine receptor alleles on PCP-mediated AIDS progression among African Americans.

    Duggal P, An P, Beaty TH, Strathdee SA, Farzadegan H, Markham RB, Johnson L, O'Brien SJ, Vlahov D, Winkler CA.

    Genes Immun. 2003 Jun;4(4):245-50.PMID: 12761559 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

    Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, Schoenbaum EE.

    J Gen Intern Med. 2002 May;17(5):377-81.PMID: 12047736 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring.

    Arnsten JH, Demas PA, Farzadegan H, Grant RW, Gourevitch MN, Chang CJ, Buono D, Eckholdt H, Howard AA, Schoenbaum EE.

    Clin Infect Dis. 2001 Oct 15;33(8):1417-23. Epub 2001 Sep 5.PMID: 11550118 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Tampons as a self-administered collection method for the detection and quantification of genital HIV-1.

    Webber MP, Schoenbaum EE, Farzadegan H, Klein RS.

    AIDS. 2001 Jul 27;15(11):1417-20.PMID: 11504963 [PubMed - indexed for MEDLINE]Related articles

    12.

    Short tandem repeat methodology for genotypic identification of single-person versus multi-person use of syringes.

    Shrestha S, Strathdee SA, Brahmbhatt H, Farzadegan H, Vlahov D, Smith MW.

    AIDS. 2000 Jul 28;14(11):1507-13.PMID: 10983637 [PubMed - indexed for MEDLINE]Related articles

    13.

    Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection.

    Shankarappa R, Margolick JB, Gange SJ, Rodrigo AG, Upchurch D, Farzadegan H, Gupta P, Rinaldo CR, Learn GH, He X, Huang XL, Mullins JI.

    J Virol. 1999 Dec;73(12):10489-502.PMID: 10559367 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The effect of drug-injection behavior on genetic evolution of HIV-1.

    Carneiro M, Yu XF, Lyles C, Templeton A, Weisstein AE, Safaeian M, Farzadegan H, Vlahov D, Markham RB.

    J Infect Dis. 1999 Oct;180(4):1025-32.PMID: 10479127 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparison of clinical manifestations of HIV infection among women by risk group, CD4+ cell count, and HIV-1 plasma viral load. HER Study Group. HIV Epidemiology Research.

    Rompalo AM, Astemborski J, Schoenbaum E, Schuman P, Carpenter C, Holmberg SD, Warren DL, Farzadegan H, Vlahov D, Smith DK.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 15;20(5):448-54.PMID: 10225226 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men.

    Lyles CM, Graham NM, Astemborski J, Vlahov D, Margolick JB, Saah AJ, Farzadegan H.

    Eur J Epidemiol. 1999 Feb;15(2):99-108.PMID: 10204638 [PubMed - indexed for MEDLINE]Related articles

    17.

    Anti-HIV type 1 memory cytotoxic T lymphocyte responses associated with changes in CD4+ T cell numbers in progression of HIV type 1 infection.

    Rinaldo CR Jr, Gupta P, Huang XL, Fan Z, Mullins JI, Gange S, Farzadegan H, Shankarappa R, Muñoz A, Margolick JB.

    AIDS Res Hum Retroviruses. 1998 Nov 1;14(16):1423-33.PMID: 9824320 [PubMed - indexed for MEDLINE]Related articles

    18.

    Sex differences in HIV-1 viral load and progression to AIDS.

    Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Markham RB, Quinn TC, Vlahov D.

    Lancet. 1998 Nov 7;352(9139):1510-4.PMID: 9820299 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of two measures of human immunodeficiency virus (HIV) type 1 load in HIV risk groups.

    Lyles CM, Vlahov D, Farzadegan H, Astemborski J, Margolick JB, Masters BA, Schroeder J, Quinn TC.

    J Clin Microbiol. 1998 Dec;36(12):3647-52.PMID: 9817889 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline.

    Markham RB, Wang WC, Weisstein AE, Wang Z, Munoz A, Templeton A, Margolick J, Vlahov D, Quinn T, Farzadegan H, Yu XF.

    Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12568-73.PMID: 9770526 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Infection with dual-tropic human immunodeficiency virus type 1 variants associated with rapid total T cell decline and disease progression in injection drug users.

    Yu XF, Wang Z, Vlahov D, Markham RB, Farzadegan H, Margolick JB.

    J Infect Dis. 1998 Aug;178(2):388-96.PMID: 9697718 [PubMed - indexed for MEDLINE]Related articles

    22.

    Sustained cognitive decline in HIV infection: relationship to CD4+ cell count, plasma viremia and p24 antigenemia.

    Dal Pan GJ, Farzadegan H, Selnes O, Hoover DR, Miller EN, Skolasky RL, Nance-Sproson TE, McArthur JC.

    J Neurovirol. 1998 Feb;4(1):95-9.PMID: 9531016 [PubMed - indexed for MEDLINE]Related articles

    23.

    Vitamin A supplementation and human immunodeficiency virus load in injection drug users.

    Semba RD, Lyles CM, Margolick JB, Caiaffa WT, Farzadegan H, Cohn S, Vlahov D.

    J Infect Dis. 1998 Mar;177(3):611-6.PMID: 9498439 [PubMed - indexed for MEDLINE]Related articles

    24.

    Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count.

    Vlahov D, Graham N, Hoover D, Flynn C, Bartlett JG, Margolick JB, Lyles CM, Nelson KE, Smith D, Holmberg S, Farzadegan H.

    JAMA. 1998 Jan 7;279(1):35-40.PMID: 9424041 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Diagnosis of human immunodeficiency virus infection using citrated whole blood.

    Sharma UK, Song HF, Willingham FF, Hannig J, Flexner C, Farzadegan H, Nicolau C, Schwartz DH.

    Clin Diagn Lab Immunol. 1997 May;4(3):261-3.PMID: 9144360 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Vitamin A levels and human immunodeficiency virus load in injection drug users.

    Semba RD, Farzadegan H, Vlahov D.

    Clin Diagn Lab Immunol. 1997 Jan;4(1):93-5.PMID: 9008289 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion.

    Farzadegan H, Henrard DR, Kleeberger CA, Schrager L, Kirby AJ, Saah AJ, Rinaldo CR Jr, O'Gorman M, Detels R, Taylor E, Phair JP, Margolick JB.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15;13(5):448-55.PMID: 8970472 [PubMed - indexed for MEDLINE]Related articles

    28.

    The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study.

    Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ.

    J Infect Dis. 1996 Dec;174(6):1332-6.PMID: 8940228 [PubMed - indexed for MEDLINE]Related articles

    29.

    Detection of Kaposi's sarcoma herpesvirus DNA in semen of homosexual men with Kaposi's sarcoma.

    Gupta P, Singh MK, Rinaldo C, Ding M, Farzadegan H, Saah A, Hoover D, Moore P, Kingsley L.

    AIDS. 1996 Nov;10(13):1596-8. No abstract available. PMID: 8931799 [PubMed - indexed for MEDLINE]Related articles

    30.

    HIV-1 survival kinetics in peritoneal dialysis effluent.

    Farzadegan H, Ford D, Malan M, Masters B, Scheel PJ Jr.

    Kidney Int. 1996 Nov;50(5):1659-62.PMID: 8914033 [PubMed - indexed for MEDLINE]Related articles

    31.

    Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells.

    Markham RB, Schwartz DH, Templeton A, Margolick JB, Farzadegan H, Vlahov D, Yu XF.

    J Virol. 1996 Oct;70(10):6947-54.PMID: 8794338 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Racial differences in rate of CD4 decline in HIV-1-infected homosexual men.

    Easterbrook PJ, Farzadegan H, Hoover DR, Palenicek J, Chmiel JS, Kaslow RA, Saah AJ.

    AIDS. 1996 Sep;10(10):1147-55.PMID: 8874633 [PubMed - indexed for MEDLINE]Related articles

    33.

    Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group.

    Scott WA, Brambilla D, Siwak E, Beatty C, Bremer J, Coombs RW, Farzadegan H, Fiscus SA, Hammer SM, Hollinger FB, Khan N, Rasheed S, Reichelderfer PS.

    J Clin Microbiol. 1996 Sep;34(9):2312-5.PMID: 8862609 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis.

    Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, Szklo M.

    Circulation. 1996 Sep 1;94(5):922-7.PMID: 8790026 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users.

    Manoff SB, Farzadegan H, Muñoz A, Astemborski JA, Vlahov D, Rizzo RT, Solomon L, Graham NM.

    J Infect Dis. 1996 Aug;174(2):299-308.PMID: 8699059 [PubMed - indexed for MEDLINE]Related articles

    36.

    Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.

    Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, Huang GT, Yang PM, Lee H, Chen CJ.

    Cancer Epidemiol Biomarkers Prev. 1996 Mar;5(3):173-8.PMID: 8833617 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Relationship between infectious cell-associated human immunodeficiency virus type 1 load, T lymphocyte subsets, and stage of infection in homosexual men.

    Margolick JB, Farzadegan H, Hoover DR, Saah AJ.

    J Infect Dis. 1996 Feb;173(2):468-71.PMID: 8568314 [PubMed - indexed for MEDLINE]Related articles

    38.

    Diagnostic utility of immune-complex-dissociated p24 antigen detection in perinatally acquired HIV-1 infection in Rwanda.

    Bulterys M, Farzadegan H, Chao A, Dushimimana A, Voltz A, Nawrocki P, Kurawige JB, Saah AJ.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):186-91.PMID: 7552484 [PubMed - indexed for MEDLINE]Related articles

    39.

    Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.

    Henrard DR, Daar E, Farzadegan H, Clark SJ, Phillips J, Shaw GM, Busch MP.

    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jul 1;9(3):305-10.PMID: 7788430 [PubMed - indexed for MEDLINE]Related articles

    40.

    Recovery of human immunodeficiency virus from peritoneal dialysis effluent.

    Scheel PJ Jr, Farzadegan H, Ford D, Malan M, Watson A.

    J Am Soc Nephrol. 1995 May;5(11):1926-9.PMID: 7620089 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression.

    Künzi MS, Farzadegan H, Margolick JB, Vlahov D, Pitha PM.

    J Infect Dis. 1995 Apr;171(4):822-8.PMID: 7706808 [PubMed - indexed for MEDLINE]Related articles

    42.

    Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users.

    Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D.

    J Infect Dis. 1995 Apr;171(4):797-804.PMID: 7706805 [PubMed - indexed for MEDLINE]Related articles

    43.

    Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland.

    Gershon RR, Vlahov D, Farzadegan H, Alter MJ.

    Infect Control Hosp Epidemiol. 1995 Apr;16(4):194-7.PMID: 7636165 [PubMed - indexed for MEDLINE]Related articles

    44.

    Association between anti-CD4 antibodies and a decline in CD4+ lymphocytes in human immunodeficiency virus type 1 seroconverters.

    Keay S, Wecksler W, Wasserman SS, Margolick J, Farzadegan H.

    J Infect Dis. 1995 Feb;171(2):312-9.PMID: 7844366 [PubMed - indexed for MEDLINE]Related articles

    45.

    Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.

    Busch MP, Lee LL, Satten GA, Henrard DR, Farzadegan H, Nelson KE, Read S, Dodd RY, Petersen LR.

    Transfusion. 1995 Feb;35(2):91-7.PMID: 7825218 [PubMed - indexed for MEDLINE]Related articles

    46.

    Microsatellite instability in primary neoplasms from HIV + patients.

    Bedi GC, Westra WH, Farzadegan H, Pitha PM, Sidransky D.

    Nat Med. 1995 Jan;1(1):65-8.PMID: 7584955 [PubMed - indexed for MEDLINE]Related articles

    47.

    Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men.

    Bagasra O, Farzadegan H, Seshamma T, Oakes JW, Saah A, Pomerantz RJ.

    AIDS. 1994 Dec;8(12):1669-74.PMID: 7888115 [PubMed - indexed for MEDLINE]Related articles

    48.

    Effects of psoralen plus UVA radiation (PUVA) on HIV-1 in human beings: a pilot study.

    Horn TD, Morison WL, Farzadegan H, Zmudzka BZ, Beer JZ.

    J Am Acad Dermatol. 1994 Nov;31(5 Pt 1):735-40.PMID: 7929918 [PubMed - indexed for MEDLINE]Related articles

    49.

    HIV-1 antibodies and serology.

    Farzadegan H.

    Clin Lab Med. 1994 Jun;14(2):257-69. Review.PMID: 7924191 [PubMed - indexed for MEDLINE]Related articles

    50.

    Detection of human immunodeficiency virus type 1 infection by polymerase chain reaction in a cohort of seronegative intravenous drug users.

    Farzadegan H, Vlahov D, Solomon L, Muñoz A, Astemborski J, Taylor E, Burnley A, Nelson KE.

    J Infect Dis. 1993 Aug;168(2):327-31.PMID: 8335969 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...